Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-06-27 @ 7:21 PM
Study NCT ID:
NCT01513551
Status:
COMPLETED
Last Update Posted:
2018-12-13
First Post:
2011-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
V114-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None